Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                CDERLearn Training and Education

CDERLearn Training and Education Home
          Training and Continuing Education
          CDERLearn Training and Education
          Drug Approval Case StudiesCDERLearn Training and Education Drug Approval Case Studies
  
  	
    Share
    Post
    Linkedin

    Email
    PrintFact Sheet (PDF - 242 KB)

FDA is introducing a new learning tool for patients and patient advocacy groups, health professionals, small business, and pharmaceutical and clinical innovators designed to advance knowledge of drug regulatory processes. Each case study promotes active learning through exercises, instructor-led discussions, and quizzes.

The first case study, *Drug Approval: Bringing a New Drug to the Market*, is a detailed and engaging learning experience on how to navigate the drug approval process from conducting nonclinical testing and clinical trials to submitting a new drug application to FDA.

We plan to develop new drug case studies that address other regulatory activities. If you have an idea for a case study topic, please contact the Professional Affairs and Stakeholders Engagement (PASE) group at cderpase@fda.hhs.gov.

Case Study 1: Drug Approval: Bringing a New Drug to the Market (PDF - 426 KB)

                                                                                  Content current as of:
      06/09/2022
              
              
Regulated Product(s)
		 DrugsCDERLearn Training and Education
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop